Bone Marrow Stroma–Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor
Taghi Manshouri(The University of Texas MD Anderson Cancer Center), Srđan Verstovšek(Unknown), David Harris(University of Udine), Chad J. Creighton(Baylor College of Medicine), Ying Zhang(Pennsylvania State University), Ana Livun(The University of Texas MD Anderson Cancer Center), Jan A. Burger(The University of Texas MD Anderson Cancer Center), Zeev Estrov(The University of Texas MD Anderson Cancer Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Alfonso Quintás-Cardama(The University of Texas MD Anderson Cancer Center), Liza Knez(The University of Texas MD Anderson Cancer Center)
Cited by 102
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k